Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).

Running, not enrolling · Phase 1

Conditions studied: Healthy

In brief

Researchers are looking for new ways to prevent cancers related to human papillomavirus (HPV). HPV is a common virus that can cause an infection. There are many different types of HPV. Most people's immune system can fight HPV infection and it goes away without treatment. For some people, HPV infections can last longer and may cause cancer years later. A standard vaccine to prevent HPV-related cancers is GARDASIL®9 (G9). G9 protects against 9 types of HPV but it does not protect against other types of HPV. The study vaccine (called V540B) is designed to protect against the same HPV types that G9 protects against plus other HPV types. The main goal of this study is to learn about the safety of V540B in healthy adults and if people tolerate it.

Key facts

Study ID

NCT06623409

Run by

Merck Sharp & Dohme LLC

People needed

72

Starts

2024-11-12

Expected to finish

2026-11-20

Last updated by the study team

2025-08-03

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The key inclusion criteria include but are not limited to the following:
• Is in good health based on medical history, physical examination, vital sign (VS) measurements and electrocardiograms (ECGs) performed before randomization.

You may not qualify if…

• The key exclusion criteria include but are not limited to the following:
• Has a history of abnormal Pap smears, HPV- related external genital lesions (eg,condyloma acuminate, vulval intraepithelial neoplasia (VIN), or prostatic intraepithelial neoplasia (PIN)) or external genital cancer (eg, penile cancer), HPV-related vaginal or anal lesions (eg, condyloma acuminata or vaginal intraepithelial neoplasia (VaIN)) or vaginal or anal cancer.
• Has a history of cancer (malignancy).
• Has received any HPV vaccine or is expected to receive any HPV vaccine during the study, outside the protocol.

Where it is running

• Anaheim Clinical Trials ( Site 0002) — Anaheim, California, United States
• California Clinical Trials Medical Group managed by PAREXEL ( Site 0008) — Glendale, California, United States
• Velocity Clinical Research, Hallandale Beach ( Site 0003) — Hallandale, Florida, United States
• Research Centers of America ( Hollywood ) ( Site 0001) — Hollywood, Florida, United States
• Velocity Clinical Research, Omaha ( Site 0005) — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.